Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunization against SIVmne in macaques using multigenic DNA vaccines.

S P Mossman1, C C Pierce, M N Robertson

  • 1Seattle Biomedical Research Institute, WA 98109-1651, USA.

Journal of Medical Primatology
|December 11, 1999
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Angle-independent spectropolarimetric target classification using machine learning.

Applied optics·2025
Same author

Author Correction: Continued Atlantic overturning circulation even under climate extremes.

Nature·2025
Same author

Continued Atlantic overturning circulation even under climate extremes.

Nature·2025
Same author

Climate-driven variability of the Southern Ocean CO<sub>2</sub> sink.

Philosophical transactions. Series A, Mathematical, physical, and engineering sciences·2023
Same author

Fine-mapping the immunodominant antibody epitopes on consensus sequence-based HIV-1 envelope trimer vaccine candidates.

NPJ vaccines·2022
Same author

COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models.

Research square·2021

DNA vaccination strategies for simian immunodeficiency virus (SIV) in macaques showed partial success. Some DNA-vaccinated monkeys controlled virus loads, correlating with a T helper 1 immune response.

Area of Science:

  • Immunology
  • Virology
  • Vaccine Development

Background:

  • Simian immunodeficiency virus (SIV) infection in macaques serves as a model for human immunodeficiency virus (HIV) research.
  • Developing effective vaccines against SIV is crucial for advancing HIV vaccine strategies.

Purpose of the Study:

  • To evaluate the immunogenicity and efficacy of DNA-based vaccines against SIV in a macaque model.
  • To assess the correlation between immune responses and viral control post-challenge.

Main Methods:

  • Cloning of SIVmne genes into expression vectors for in vitro and in vivo studies.
  • Immunization of macaques (Macaca fascicularis) with plasmid DNA or DNA prime-boosted with recombinant gp160 plus Gag-Pol particles.
  • Intrarectal challenge with SIVmne and monitoring of viral loads and CD4+ T-cell counts.

Related Experiment Videos

Main Results:

  • All vaccinated and control macaques became infected post-challenge.
  • Three out of four DNA-vaccinated macaques maintained low viral loads and CD4+ cell counts one year post-infection.
  • Both vaccine protocols induced antibodies and T-cell responses to gp160.
  • A dominant T helper 1 (Th1) cytokine profile in peripheral blood mononuclear cells (PBMC) correlated with better viral control.

Conclusions:

  • DNA vaccination strategies can elicit immune responses and partially control SIV replication in macaques.
  • A Th1-biased immune response appears critical for controlling SIV infection post-vaccination.
  • Further optimization of SIV vaccine approaches is warranted.